Cryoport to provide cold chain logistics for clinicial trial

Research,laboratory,science,test tube

Cryogenics logistics company Cryoport, Inc., will support TiGenix as it conducts its SEPCELL phase Ib/IIa clinical study to evaluate the safety and efficacy of expanded Cx611 allogeneic adipose‐derived stem cells (eASCs) for the treatment of sepsis in adult patients with severe community‐acquired bacterial pneumonia and admitted to the intensive care ...

You must be a subsciber to read this content

If you already subscribe, please sign-in now

Subscribe to Gas World


Get instant access to must-read content from top industry writers!

To access hundreds of features, subscribe today! Discover the in-depth content our subscribers receive every month by reading this week’s free feature. Join gasworld and become a subscriber to access all of our content online from just $270.